MKTWMARKETWISE, INC.

Nasdaq https://marketwise.agency/


$ 1.64 $ 0.05 (3.14 %)    

Friday, 19-Apr-2024 15:40:35 EDT
QQQ $ 414.59 $ -8.76 (-2.07 %)
DIA $ 379.83 $ 1.96 (0.52 %)
SPY $ 494.96 $ -4.36 (-0.87 %)
TLT $ 89.15 $ 0.32 (0.36 %)
GLD $ 221.02 $ 0.69 (0.31 %)
$ 1.64
$ 1.60
$ 0.00 x 0
$ 1.64 x 100
$ 1.60 - $ 1.64
$ 1.15 - $ 3.59
89,914
na
54.63M
$ 1.24
$ 30.66
TBD
na
na ($ 0.12)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-07-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-Q
9 03-10-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 07-19-2021 06-30-2021 10-Q
12 05-24-2021 03-31-2021 10-Q
13 03-22-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-maintains-neutral-on-marketwise-lowers-price-target-to-2

UBS analyst Alex Kramm maintains Marketwise (NASDAQ:MKTW) with a Neutral and lowers the price target from $3.5 to $2.

Core News & Articles

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 ubs-downgrades-marketwise-to-neutral-raises-price-target-to-35

UBS analyst Alex Kramm downgrades Marketwise (NASDAQ:MKTW) from Buy to Neutral and raises the price target from $3 to $3.5.

 needham-reiterates-buy-on-marketwise-maintains-3-price-target

Needham analyst Kyle Peterson reiterates Marketwise (NASDAQ:MKTW) with a Buy and maintains $3 price target.

 marketwise-q3-sales-10615m-beat-10480m-estimate

Marketwise (NASDAQ:MKTW) reported quarterly sales of $106.15 million which beat the analyst consensus estimate of $104.80 milli...

 earnings-scheduled-for-november-9-2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

 marketwise-declared-a-special-dividend-to-shareholders-of-class-a-common-stock-of-015share

Given the strong balance sheet of the Company, and after a capital allocation review, the Company also announced a special divi...

 marketwise-appoints-its-founder-f-porter-stansberry-as-chairman-and-chief-executive-officer-effective-immediately

The Board of Directors of MarketWise appointed MarketWise founder F. Porter Stansberry as Chairman of the Board and Chief Exe...

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 59 companies achieved new lows for the year.

 stocks-that-hit-52-week-lows-on-monday

  During Monday, 102 stocks hit new 52-week lows.

 marketwise-repudiates-false-claims-in-porter-stansberrys-august-11-2023-letter

MarketWise, Inc. (NASDAQ:MKTW) ("MarketWise" or the "Company"), a leading multi-brand digital subscription serv...

 marketwise-and-2-other-stocks-under-2-insiders-are-buying

The Dow Jones closed lower by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confid...

 needham-reiterates-buy-on-marketwise-maintains-3-price-target

Needham analyst Kyle Peterson reiterates Marketwise (NASDAQ:MKTW) with a Buy and maintains $3 price target.

Core News & Articles

By the close of today, August 10, 2023, Value Line (NASDAQ:VALU) will issue a dividend payout of $0.28 per share, resulting in ...

 marketwise-q2-sales-10360m-miss-10932m-estimate

Marketwise (NASDAQ:MKTW) reported quarterly sales of $103.60 million which missed the analyst consensus estimate of $109.32 mil...

 earnings-scheduled-for-august-10-2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share o...

 jmp-securities-reiterates-market-outperform-on-marketwise-maintains-55-price-target

JMP Securities analyst Devin Ryan reiterates Marketwise (NASDAQ:MKTW) with a Market Outperform and maintains $5.5 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION